封面
市場調查報告書
商品編碼
1345282

全球生命科學分析市場 - 市場規模、佔有率、成長分析:按組件(軟體、服務)、按類型(報告、說明分析) - 產業預測 (2023-2030)

Global Life Science Analytics Market Size, Share, Growth Analysis, By Component(Software, and Services), By Type(Reporting, Descriptive) - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2021年全球生命科學分析市場規模達83.6億美元。預計2023年至2030年該市場將以7.7%的年複合成長率成長,從2022年的90億美元成長到2030年的163億美元。

該市場的主要成長促進因素包括電子健康記錄、臨床試驗、基因組學、穿戴式裝置和社群媒體等各種資訊來源的醫療資料量的增加。在挑戰的同時,巨大的機會也隨之出現,例如透過應用人工智慧和機器學習演算法來徹底改變藥物研發和個人化醫療的潛力。醫療保健資料的可用性推動了生命科學領域對實證決策的需求,推動了全球生命科學分析市場的發展。儘管資料隱私和整合等挑戰仍然存在,但該市場為利用分析徹底改變藥物開發、患者照護和整體營運效率的組織提供了令人興奮的機會。

現實世界資料(包括電子健康記錄、穿戴式裝置和社群媒體)的使用不斷增加,推動對分析解決方案的需求。真實世界的資料為患者結果、治療效果和人口健康提供了寶貴的見解,促進生命領域領域的證據驅動決策。

將人工智慧和機器學習演算法融入生命科學分析解決方案有可能重塑藥物研發發現、最佳化臨床試驗和個體化醫療保健。這些技術透過熟練地分析大量資料集、識別模式和預測結果,為更有效和更有針對性的干涉措施鋪平了道路。

在生命科學分析中處理敏感的患者資料會引發資料隱私和安全問題。 GDPR 和 HIPAA 等嚴格法規在資料治理和病患保密方面為組織帶來了障礙。

本報告調查全球生命科學分析市場,並提供了市場概述,包括按組成、類型、地區和參與市場的公司概況分類的趨勢。

目錄

執行摘要

母市場分析

市場規模

  • 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務

關鍵市場洞察

  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 智慧財產權分析
  • 趨勢分析
  • 啟動分析
  • 原料分析
  • 創新矩陣
  • 研發線產品分析
  • 總體經濟指標
  • 頂級投資分析
  • 關鍵成功要素
  • 競爭程度

市場動態及前景

  • 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
  • 法規狀況
  • 波特分析

全球生命科學分析市場(按組成部分)

  • 市場概況
  • 軟體
  • 服務

全球生命科學分析市場,依類型

  • 市場概況
  • 報告
  • 說明分析
  • 預測分析
  • 規範性分析

全球生命科學分析市場(按地區)

  • 市場概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東、非洲

競爭形勢

  • 主要企業簡介
    • IQVIA Holdings Inc.
    • SAS Institute Inc.
    • Accenture plc
    • Cognizant Technology Solutions Corporation
    • IBM Corporation
    • Oracle Corporation
    • Microsoft Corporation
    • Optum, Inc.
    • SAP SE
    • EXLService Holdings, Inc.
    • PAREXEL International Corporation
    • SCIO Health Analytics
    • Wipro Limited
    • PricewaterhouseCoopers LLP
    • TIBCO Software Inc.
    • Take Solutions Limited
    • Mu Sigma Inc.
    • Genpact Limited
    • QuintilesIMS Holdings, Inc.
    • Palantir Technologies Inc.
簡介目錄
Product Code: SQMIG35G2143

The global market for Life Science Analytics was worth USD 8.36 billion in 2021 and is projected to expand from USD 9 billion in 2022 to USD 16.30 billion by 2030, with a CAGR of 7.7% during 2023-2030.

The key growth drivers for this market include the escalating volume of healthcare data from various sources like electronic health records, clinical trials, genomics, wearables, and social media. Amid challenges, significant opportunities arise, such as the potential transformation of drug discovery and personalized medicine through the application of AI and ML algorithms. The demand for evidence-based decision-making in the life sciences sector, driven by the availability of healthcare data, is propelling the global life science analytics market. While challenges like data privacy and integration persist, the market offers exciting chances for organizations to harness analytics for innovation in drug development, patient care, and overall operational efficiency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Life Science Analytics Market Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Life Science Analytics Market Segmental Analysis Report

The global life science analytics market is segmented on the basis of component, type, and region. Based on component, the market is segmented into software, and services. In terms of type, the market is segmented into reporting, descriptive, predictive, and prescriptive. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Life Science Analytics Market Driver

Surging Uptake of Real-World Data

The increasing utilization of real-world data, encompassing electronic health records, wearables, and social media, is propelling the demand for analytics solutions. Real-world data furnishes valuable insights into patient outcomes, treatment efficacy, and population health, thereby facilitating evidence-driven decision-making within the life sciences sector.

Advancements in Artificial Intelligence (AI) and Machine Learning (ML)

The incorporation of AI and ML algorithms into life science analytics solutions holds the potential to reshape drug discovery, optimize clinical trials, and personalize medicine. These technologies adeptly analyze extensive data sets, recognize patterns, and forecast outcomes, paving the way for more effective and precise interventions.

Global Life Science Analytics Market Restraint

Data Privacy and Security Apprehensions

Navigating sensitive patient data in life science analytics raises concerns about data privacy and security. Stringent regulations like GDPR and HIPAA impose hurdles on organizations in terms of data governance and preserving patient confidentiality.

Shortage of Skilled Workforce

The scarcity of proficient data scientists and analysts well-versed in both life sciences and analytics presents a noteworthy challenge. Extracting meaningful insights from intricate healthcare data necessitates specialized knowledge, potentially limiting the seamless implementation of analytics solutions.

Trends in the Global Life Science Analytics Market

Rising Focus on Instantaneous Analytics: The sector is observing a shift towards real-time analytics, allowing entities to make prompt decisions and adapt to dynamic market scenarios. Real-time data amalgamation, processing, and analysis are becoming imperative for gaining a competitive advantage in areas like personalized medicine, patient monitoring, and supply chain optimization.

Prioritizing Value-Based Care: The growing uptake of value-based care models, which link reimbursement to patient outcomes, is fueling the demand for analytics solutions. Life science organizations are utilizing analytics to showcase the value and efficacy of their offerings, streamline patient care routes, and enhance health economics.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Life Science Analytics Market by Component
    • Market Overview
    • Software
    • and Services
  • Global Life Science Analytics Market by Type
    • Market Overview
    • Reporting
    • Descriptive
    • Predictive
    • and Prescriptive
  • Global Life Science Analytics Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • IQVIA Holdings Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • SAS Institute Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Accenture plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Cognizant Technology Solutions Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • IBM Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Oracle Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Microsoft Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Optum, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • SAP SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • EXLService Holdings, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • PAREXEL International Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • SCIO Health Analytics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Wipro Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • PricewaterhouseCoopers LLP (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • TIBCO Software Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Take Solutions Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mu Sigma Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Genpact Limited (Bermuda)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • QuintilesIMS Holdings, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Palantir Technologies Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments